[Effect of clock gene PER1 knockdown on clock gene networks in human oral squamous cell carcinoma]

Zhao Qin1, Ao Yiran1, Yang Kai1

  • 1Dept. of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

Abstract

Insights

The clock gene PER1 influences other clock genes in oral cancer cells, affecting cell proliferation and apoptosis. PER1 knockdown alters the expression of key genes within the cellular clock network, highlighting its regulatory role.

Area of Science:

  • Molecular Biology
  • Chronobiology
  • Cancer Research

Background:

  • Circadian rhythm genes, or clock genes, regulate physiological processes.
  • Dysregulation of clock genes is implicated in various cancers, including oral squamous cell carcinoma (OSCC).
  • The specific role of the Period 1 (PER1) gene in OSCC clock gene networks requires further elucidation.

Purpose of the Study:

  • To investigate the impact of PER1 knockdown on the expression of other clock genes in OSCC cells.
  • To determine the effect of PER1 modulation on the proliferation and apoptosis of OSCC cells.

Main Methods:

  • PER1 was knocked down in SCC15 human OSCC cells using short hairpin RNAs (shRNAs).
  • Cell proliferation and apoptosis were assessed using flow cytometry.
  • Quantitative real-time PCR (qRT-PCR) was employed to measure mRNA expression levels of multiple clock genes.

Main Results:

  • PER1 knockdown led to increased cell proliferation and decreased apoptosis in SCC15 cells (P<0.05).
  • Significant alterations in mRNA expression were observed for PER2, DEC1, DEC2, CRY1, CRY2, NPAS2, PER3, TIM, RORA, and REV-ERBA.
  • Expression levels of CLOCK, BMAL1, and CKIE remained largely unchanged.

Conclusions:

  • The clock gene PER1 plays a crucial regulatory role in the cellular clock gene network within OSCC.
  • PER1 influences the expression of numerous other clock genes, impacting cellular processes like proliferation and apoptosis.
  • These findings suggest PER1 as a potential therapeutic target in oral squamous cell carcinoma.